Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01111227
Other study ID # upeclin/HC/FMB-Unesp-40
Secondary ID
Status Completed
Phase Phase 4
First received March 11, 2010
Last updated April 26, 2010
Start date March 2008
Est. completion date December 2009

Study information

Verified date April 2010
Source UPECLIN HC FM Botucatu Unesp
Contact n/a
Is FDA regulated No
Health authority Brazil: Ethics Committee
Study type Interventional

Clinical Trial Summary

The aim of this study is to assess the profile of cytokines IL-1beta, IL-6, IL-8, IL-10, IL-12 and TNF-alpha under inhalation anesthesia with isoflurane and intravenous anesthesia with propofol in healthy patients subjected to minimally invasive elective surgeries.


Description:

Twenty ASA-I patients, subjected to otorhinolaryngology surgery, were randomly allocated in one group to receive anesthesia with isoflurane 1 MAC (minimum alveolar concentration) (n = 20). Other group with twenty ASA-I patients received propofol 2 to 4 microgram mL-1 (n = 20).

Fentanyl 5 mg kg-1 and rocuronium bromide 0.6 mg kg-1 were also administered to all patients. Venous blood (10 mL) was collected from each patient at each of the following times: before the beginning of surgery and anesthesia (T1), 2 h after the beginning of surgery (T2), and on the day after the anesthetic-surgical procedure (T3).

Plasma concentrations of interleukins IL-1beta, IL-6, IL-8, IL-10 and IL-12 and tumor necrosis factor (TNF-alpha) were measured in each sample through flow cytometry technique by using the method Cytometric Bead Array (CBA). Venous blood samples from fifteen volunteers not subjected to stress were also collected as control, and the same cytokines were measured.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date December 2009
Est. primary completion date December 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Patients in good health American Society of Anesthesia status physical I

- Elective minor surgery

- General anesthesia

Exclusion Criteria:

- Smokers

- Alcoholics

- Previous medication or radiation

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Drug:
Propofol and isoflurane
Comparison of two anesthetic drugs

Locations

Country Name City State
Brazil Botucatu Medical School, UNESP Botucatu São Paulo

Sponsors (2)

Lead Sponsor Collaborator
UPECLIN HC FM Botucatu Unesp Fundação de Amparo à Pesquisa do Estado de São Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of cytokines profile Before surgery and anesthesia, 2h after anesthesia and at the following day of the surgery Yes
Secondary Evaluation of pro and anti-inflammatory cytokines before surgery and anesthesia, 2h after anesthesia and at the following day of the surgery Yes
See also
  Status Clinical Trial Phase
Completed NCT00854178 - Toxicogenomic and Immunocytotoxic Effects of Propofol and Isoflurane Anesthetics in Patients Undergoing Elective Surgery Phase 4